<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02102191</url>
  </required_header>
  <id_info>
    <org_study_id>972CE</org_study_id>
    <secondary_id>23</secondary_id>
    <nct_id>NCT02102191</nct_id>
  </id_info>
  <brief_title>Acute Physiological Effects of Electronic Sigarette vs Cigarette Smoking</brief_title>
  <official_title>Acute Physiological Effects of Electronic Sigarette vs Cigarette Smoking: a RCT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliero-Universitaria di Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Salvatore Maugeri</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS Azienda Ospedaliero-Universitaria di Bologna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Because e-cigarettes do not contain or burn tobacco, they do not appear to deliver the known&#xD;
      toxins found in conventional cigarette smoke.However e-Cigarettes with low dose of tobacco&#xD;
      were found to have immediate adverse physiologic effects after short-term use that are&#xD;
      similar to some of the effects seen with tobacco smoking.&#xD;
&#xD;
      In this study we wanted to assess the short-time effect of one e-cigarette with no tobacco vs&#xD;
      a &quot;traditional&quot; cigarette.&#xD;
&#xD;
      10 n-smoking subject and 10 actual smokers will be enrolled in the randomized trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      On day 1 the subjects will be asked to smoke either the e-cigarette or a &quot;traditional&quot; one&#xD;
      for 5 minutes. On day 2 the subject will be ask to smoke for 5 minutes the other kind of&#xD;
      cigarette.&#xD;
&#xD;
      Exhaled Nitric Oxide will be measured in a sitting position with a nose clip using an&#xD;
      analyzer equipped with a software program. The patient will be instructed to inhale as deeply&#xD;
      as possible to total lung capacity through a filter mouthpiece and consecutively exhale at a&#xD;
      mouth fl ow rate of 50 mL/s for 10 s. Three consecutive trials will be performed with a 30-s&#xD;
      interval.&#xD;
&#xD;
      Dynamic Lung Volumes: Flows and lung volumes will be measured in the sitting position, a&#xD;
      spirometry system (heated pneumotach, with the highest FEV 1 recorded in line with pulmonary&#xD;
      guidelines. Spirometry will be measured according to the recommendations of the American&#xD;
      Thoracic Society/European Respiratory Society task force guidelines. FEV 1, FVC, FEV 1 %,&#xD;
      peak expiratory fl ow (PEF), and maximal expiratory fl ow (MEF) at 25%, 50%, and 75% of vital&#xD;
      capacity will be measured. Each maneuver will be repeated for at least three technically&#xD;
      acceptable forced expiratory fl ow curves.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>spirometric data</measure>
    <time_frame>five minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>nitric oxyde level</measure>
    <time_frame>5 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Individuality</condition>
  <arm_group>
    <arm_group_label>cigarette</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>common cigarette sold in the stores</description>
  </arm_group>
  <arm_group>
    <arm_group_label>e-cigarette</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>e-cigarette (Ovale Elips)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>e-cigarette</intervention_name>
    <description>smoking cigarette without tobacco</description>
    <arm_group_label>cigarette</arm_group_label>
    <arm_group_label>e-cigarette</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cigarette</intervention_name>
    <description>smoking cigarette with tobacco</description>
    <arm_group_label>cigarette</arm_group_label>
    <arm_group_label>e-cigarette</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  10 no smoking healthy individuals&#xD;
&#xD;
          -  10 smoking (&gt;20 pack/yr) healthy individuals&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pre-existing diseases&#xD;
&#xD;
          -  FEV1/FVC ratio&lt;70%&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>stefano nava, md</last_name>
    <role>Study Chair</role>
    <affiliation>AO Sant'Orsola</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri</name>
      <address>
        <city>Pavia</city>
        <state>Province</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <study_first_submitted>March 27, 2014</study_first_submitted>
  <study_first_submitted_qc>March 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2014</study_first_posted>
  <last_update_submitted>October 5, 2014</last_update_submitted>
  <last_update_submitted_qc>October 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Azienda Ospedaliero-Universitaria di Bologna</investigator_affiliation>
    <investigator_full_name>dr. Stefano Nava</investigator_full_name>
    <investigator_title>professor of respiratory disease</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

